|
DNAJC8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64769997645919E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.27819999718693E-08 |
| Normal-vs-Stage2 |
2.38759999999782E-05 |
| Normal-vs-Stage3 |
9.9766000016821E-08 |
| Normal-vs-Stage4 |
2.95340000233679E-08 |
| Stage1-vs-Stage2 |
3.610800E-01 |
| Stage1-vs-Stage3 |
2.454800E-01 |
| Stage1-vs-Stage4 |
1.147020E-01 |
| Stage2-vs-Stage3 |
9.712400E-01 |
| Stage2-vs-Stage4 |
6.189800E-01 |
| Stage3-vs-Stage4 |
5.253000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.01820005152342E-09 |
| Normal-vs-AfricanAmerican |
3.977900E-02 |
| Normal-vs-Asian |
5.826900E-04 |
| Caucasian-vs-AfricanAmerican |
2.779200E-01 |
| Caucasian-vs-Asian |
2.843200E-01 |
| AfricanAmerican-vs-Asian |
7.891800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.36430003247779E-09 |
| Normal-vs-Female |
1.45520000494059E-08 |
| Male-vs-Female |
1.955620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.37290000001844E-06 |
| Normal-vs-Age(41-60Yrs) |
6.4757999962417E-08 |
| Normal-vs-Age(61-80Yrs) |
1.3855000480234E-09 |
| Normal-vs-Age(81-100Yrs) |
1.569470E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.298000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.879700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.465200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.860100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.404000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.627600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.036000E-01 |
| Classical-VS-Follicular |
1.583620E-01 |
| Classical-VS-Other |
4.818000E-01 |
| Classical-VS-Normal |
4.92510000005275E-06 |
| Tall-VS-Follicular |
9.595400E-01 |
| Tall-VS-Other |
9.584800E-01 |
| Tall-VS-Normal |
4.10939999995197E-06 |
| Follicular-VS-Other |
9.529800E-01 |
| Follicular-VS-Normal |
2.42839999997635E-06 |
| Other-VS-Normal |
7.156900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.65219995649369E-09 |
| Normal-vs-N1 |
2.56350000116257E-08 |
| N0-vs-N1 |
1.695600E-01 |
|
|
